Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G, SINGLE Investigators.
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
NEW ENGLAND JOURNAL OF MEDICINE . 369(19): 1807-1818. Nº de citas: 542
-
Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Molina J, Lopez-Medrano F, Ruiz E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MA, Benito N, Rodriguez-Baño J, Espejo E, Pujol M.
Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy
CLINICAL MICROBIOLOGY AND INFECTION . 19(11): 1049-1057. Nº de citas: 50
-
Torres M, González C, del Romero J, Viciana P, Ocampo A, Rodríguez-Fortúnez P, Masiá M, Blanco JR, Portilla J, Rodríguez C, Hernández-Novoa B, del Amo J, Ortiz M.
Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort
JOURNAL OF CLINICAL MICROBIOLOGY . 51(11): 3512-3520. Nº de citas: 37
-
Monge-Maillo B, López-Vélez R.
Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis
Drugs . 73(17): 1889-1920. Nº de citas: 54
-
Monge-Maillo B, López-Vélez R.
Therapeutic Options for Visceral Leishmaniasis
Drugs . 73(17): 1863-1888. Nº de citas: 108
-
Ruiz-Garbajosa P, Curiao T, Tato M, Gijón D, Pintado V, Valverde A, Baquero F, Morosini MI, Coque TM, Cantón R.
Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(11): 2487-2492. Nº de citas: 42
-
Abad-Fernández M, Vallejo A, Hernández-Novoa B, Díaz L, Gutiérrez C, Madrid N, Muñoz MA, Moreno S.
Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1-Infected Individuals
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 149-153. Nº de citas: 38
-
Cervero M, Agud JL, Torres R, García-Lacalle C, Alcázar V, Jusdado JJ, Moreno S.
Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy
HIV MEDICINE . 14(9): 556-562. Nº de citas: 18
-
Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodríguez-Baño J.
Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance
CLINICAL MICROBIOLOGY AND INFECTION . 19(10): 962-968. Nº de citas: 81
-
Morosini MI, Quereda C, Gil H, Anda P, Núñez-Murga M, Cantón R, López-Vélez R.
Melioidosis in Traveler from Africa to Spain
EMERGING INFECTIOUS DISEASES . 19(10): 1656-1659. Nº de citas: 21
-
Norman FF, López-Vélez R.
Chagas Disease and Breast-feeding
EMERGING INFECTIOUS DISEASES . 19(10): 1561-1566. Nº de citas: 27
-
Cisneros JM, Cobo J, San Juan R, Montejo M, Fariñas MC.
Education on antibiotic use. Education systems and activities that work.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 31 Suppl 4: 31-37.
-
González C, Torres M, Benito A, Del Romero J, Rodríguez C, Fontillón M, Trastoy M, Viciana P, Del Amo J, Ortiz M, Hernández-Novoa B.
Anal squamous intraepithelial lesions are frequent among young HIV-infected men who have sex with men followed up at the Spanish AIDS Research Network Cohort (CoRIS-HPV)
INTERNATIONAL JOURNAL OF CANCER . 133(5): 1164-1172. Nº de citas: 19
-
Anta L, Blanco JL, Llibre JM, García F, Pérez-Elías MJ, Aguilera A, Pérez-Romero P, Caballero E, Vidal C, Cañizares A, Gutiérrez F, Dalmau D, Iribarren JA, Soriano V, de Mendoza C.
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 68(9): 1994-2002. Nº de citas: 9
-
Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O.
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
PLOS MEDICINE . 10(9): . Nº de citas: 228
-
Castronuovo D, Cacopardo B, Pinzone MR, Di Rosa M, Martellotta F, Schioppa O, Moreno S, Nunnari G.
Bone disease in the setting of HIV infection: update and review of the literature
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES . 17(18): 2413-2419. Nº de citas: 34
-
Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S.
Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials
AIDS . 27(13): 2081-2088. Nº de citas: 13
-
Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I.
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010
BMC INFECTIOUS DISEASES . 13: 382-382. Nº de citas: 18